Your browser doesn't support javascript.
loading
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
Vadivel, Chella Krishna; Willerslev-Olsen, Andreas; Namini, Martin R J; Zeng, Ziao; Yan, Lang; Danielsen, Maria; Gluud, Maria; Pallesen, Emil M H; Wojewoda, Karolina; Osmancevic, Amra; Hedebo, Signe; Chang, Yun-Tsan; Lindahl, Lise M; Koralov, Sergei B; Geskin, Larisa J; Bates, Susan E; Iversen, Lars; Litman, Thomas; Bech, Rikke; Wobser, Marion; Guenova, Emmanuella; Kamstrup, Maria R; Ødum, Niels; Buus, Terkild B.
Afiliação
  • Vadivel CK; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Willerslev-Olsen A; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Namini MRJ; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Zeng Z; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Yan L; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Danielsen M; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Gluud M; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Pallesen EMH; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Wojewoda K; Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Osmancevic A; Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Hedebo S; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Chang YT; Department of Dermatology and Venereology, University Hospital Centre (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Lindahl LM; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Koralov SB; Department of Pathology, New York University School of Medicine, New York, NY.
  • Geskin LJ; Department of Dermatology, Columbia University Irving Medical Center, New York, NY.
  • Bates SE; Division of Hematology/Oncology, Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY.
  • Iversen L; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Litman T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Bech R; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Wobser M; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
  • Guenova E; Department of Dermatology and Venereology, University Hospital Centre (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
  • Kamstrup MR; Department of Dermatology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Ødum N; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Buus TB; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Blood ; 143(15): 1496-1512, 2024 Apr 11.
Article em En | MEDLINE | ID: mdl-38170178
ABSTRACT
ABSTRACT Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus-specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Infecções Estafilocócicas / Linfoma Cutâneo de Células T / Síndrome de Sézary Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Infecções Estafilocócicas / Linfoma Cutâneo de Células T / Síndrome de Sézary Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article